Hedgehog Suppresses Paclitaxel Sensitivity by Regulating Akt-Mediated Phosphorylation of Bax in EGFR Wild-Type Non-Small Cell Lung Cancer Cells
Non-small cell lung cancer (NSCLC) is one of the most common and deadly cancers worldwide. Among NSCLC patients, almost half have wild-type epidermal growth factor receptor (EGFR WT). The primary therapeutic option for these EGFR WT NSCLC patients is chemotherapy, while NSCLC patients with EGFR muta...
Main Authors: | Yun-Chieh Tu, Wei-Chen Yeh, Hsin-Hsien Yu, Yu-Cheng Lee, Bor-Chyuan Su |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.815308/full |
Similar Items
-
Deguelin Restores Paclitaxel Sensitivity in Paclitaxel-Resistant Ovarian Cancer Cells via Inhibition of the EGFR Signaling Pathway
by: Bae S, et al.
Published: (2024-05-01) -
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma
by: Nilsson M, et al.
Published: (2022-08-01) -
Anti-glioma effect of paclitaxel mediated by specific mode electroacupuncture stimulation and the related role of the Hedgehog pathway
by: Congcong Ma, et al.
Published: (2024-07-01) -
Pan-EGFR Inhibitor Dacomitinib Resensitizes Paclitaxel and Induces Apoptosis via Elevating Intracellular ROS Levels in Ovarian Cancer SKOV3-TR Cells
by: Ye Jin Lim, et al.
Published: (2024-01-01) -
A phase Ib study of pictilisib (GDC-0941) in combination with paclitaxel, with and without bevacizumab or trastuzumab, and with letrozole in advanced breast cancer
by: Patrick Schöffski, et al.
Published: (2018-09-01)